These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20827191)

  • 21. The role of oxidized phospholipids in atherosclerosis.
    Berliner JA; Leitinger N; Tsimikas S
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S207-12. PubMed ID: 19059906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of oxidized phospholipids on phenotypic polarization and function of macrophages.
    Serbulea V; DeWeese D; Leitinger N
    Free Radic Biol Med; 2017 Oct; 111():156-168. PubMed ID: 28232205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of inflammatory responses by oxidized phospholipids: structure-function relationships.
    Furnkranz A; Leitinger N
    Curr Pharm Des; 2004; 10(8):915-21. PubMed ID: 15032694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclopentenone-containing oxidized phospholipids and their isoprostanes as pro-resolving mediators of inflammation.
    Friedli O; Freigang S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Apr; 1862(4):382-392. PubMed ID: 27422370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulating evidence for a role of oxidized phospholipids in infectious diseases.
    Matt U; Sharif O; Martins R; Knapp S
    Cell Mol Life Sci; 2015 Mar; 72(6):1059-71. PubMed ID: 25410378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory profile of oxidized phospholipids.
    Bochkov VN
    Thromb Haemost; 2007 Mar; 97(3):348-54. PubMed ID: 17334500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of TLR inhibitors for the treatment of autoimmune diseases.
    Barrat FJ; Coffman RL
    Immunol Rev; 2008 Jun; 223():271-83. PubMed ID: 18613842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Increase of Oxidized Phospholipids and the Role of Macrophages in Intraocular Inflammation.
    Hiraoka M; Abe A
    Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):23. PubMed ID: 32526032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety
    Lu J; Guo S; Xue X; Chen Q; Ge J; Zhuo Y; Zhong H; Chen B; Zhao M; Han W; Suzuki T; Zhu M; Xia L; Schneider C; Blackwell TS; Porter NA; Zheng L; Tsimikas S; Yin H
    J Biol Chem; 2017 Mar; 292(13):5378-5391. PubMed ID: 28202546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and biological activities of oxidized phospholipids.
    Bochkov VN; Oskolkova OV; Birukov KG; Levonen AL; Binder CJ; Stöckl J
    Antioxid Redox Signal; 2010 Apr; 12(8):1009-59. PubMed ID: 19686040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteasome inhibition: a new anti-inflammatory strategy.
    Elliott PJ; Zollner TM; Boehncke WH
    J Mol Med (Berl); 2003 Apr; 81(4):235-45. PubMed ID: 12700891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sparstolonin B: A Unique Anti-Inflammatory Agent.
    Yepuri N; Dhawan R; Cooney M; Pruekprasert N; Meng Q; Cooney RN
    Shock; 2019 Dec; 52(6):568-576. PubMed ID: 30807526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptors: Role in inflammation and therapeutic potential.
    Kay E; Scotland RS; Whiteford JR
    Biofactors; 2014; 40(3):284-94. PubMed ID: 24375529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidized phospholipids on alkyl-amide scaffold demonstrate anti-endotoxin and endothelial barrier-protective properties.
    Oskolkova OV; Hodzic A; Karki P; Gesslbauer B; Ke Y; Hofer DC; Bogner-Strauss JG; Galano JM; Oger C; Birukova A; Durand T; Birukov K; Bochkov V
    Free Radic Biol Med; 2021 Oct; 174():264-271. PubMed ID: 34371153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidized phospholipids as modulators of inflammation in atherosclerosis.
    Leitinger N
    Curr Opin Lipidol; 2003 Oct; 14(5):421-30. PubMed ID: 14501580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologics beyond TNF-α inhibitors and the effect of targeting the homologues TL1A-DR3 pathway in chronic inflammatory disorders.
    Tougaard P; Zervides KA; Skov S; Hansen AK; Pedersen AE
    Immunopharmacol Immunotoxicol; 2016; 38(1):29-38. PubMed ID: 26810853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
    J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized phospholipids exert a dual effect on bile acid-induced CCL2 expression in pancreatic acini.
    Mateu A; De Dios I; Manso MA; Ramudo L
    Pancreatology; 2017; 17(3):372-380. PubMed ID: 28291657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.